Stock Analysis on Net

HCA Healthcare Inc. (NYSE:HCA)

$22.49

This company has been moved to the archive! The financial data has not been updated since May 3, 2022.

Price to Earnings (P/E)
since 2011

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

HCA Healthcare Inc., P/E, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 US$

2 Data adjusted for splits and stock dividends.

3 Closing price as at the filing date of HCA Healthcare Inc. Annual Report.


The financial data reveals a distinct upward trajectory in the share price over the analyzed period, increasing consistently from $26.74 in early 2012 to $244.10 in early 2022. This tenfold growth indicates significant market confidence and a strengthening valuation over the decade.

Earnings per share exhibit variability with an initial decline from $5.63 in 2012 to a low of $3.53 in 2014, followed by a recovery and an overall upward trend peaking sharply at $22.91 in 2022. This substantial increase in the most recent year suggests an exceptional improvement in profitability or earnings quality.

The price-to-earnings (P/E) ratio fluctuates throughout the period, starting at 4.75 in 2012 and rising to a range generally between 10 and 16 in subsequent years. Despite increases in share price and EPS, the P/E ratio in 2022 is lower at 10.65 compared to previous years, indicating that the share price growth in the last year may be more closely aligned with earnings growth, or that the stock might be comparatively undervalued relative to its earnings at this point.

Overall, the trends point to substantial value creation and improved earnings performance, with periods of valuation adjustment reflecting market reassessments of the company's financial prospects. The robust rise in both share price and EPS by 2022, coupled with a moderate P/E ratio, suggests strengthened investor confidence supported by solid earnings gains.


Comparison to Competitors

HCA Healthcare Inc., P/E, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).


Comparison to Sector (Health Care Equipment & Services)

HCA Healthcare Inc., P/E, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).


Comparison to Industry (Health Care)

HCA Healthcare Inc., P/E, long-term trends, comparison to industry (health care)

Microsoft Excel

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).